Please login to the form below

Not currently logged in
Email:
Password:

immune disease

This page shows the latest immune disease news and features for those working in and with pharma, biotech and healthcare.

Leo Pharma to market AstraZeneca’s brodalumab outside Europe

Leo Pharma to market AstraZeneca’s brodalumab outside Europe

According to Leo Pharma, around 125 million people globally live with psoriasis, a chronic and inflammatory disease that is immune-mediated. ... conditions including heart disease and metabolic syndrome.

Latest news

  • Amgen and Novartis abandon Alzheimer’s drug after worsening symptoms Amgen and Novartis abandon Alzheimer’s drug after worsening symptoms

    s disease in people at high risk for developing symptoms based on age and their genetic status. ... Funding is now pouring into a number of entirely novel modalities, including approaching the disease as an immune system dysfunction.

  • Latecomer Lilly preps its IL-23 drug for Crohn’s disease Latecomer Lilly preps its IL-23 drug for Crohn’s disease

    Lilly has just presented phase 2 results with mirikizumab in moderate to severe Crohn’s – a form of inflammatory bowel disease – which reveal significant reductions in clinical and endoscopic measures of ... The data was presented at this week’s

  • FDA approves AbbVie’s psoriasis blockbuster-to-be Skyrizi FDA approves AbbVie’s psoriasis blockbuster-to-be Skyrizi

    Skyrizi builds on AbbVie's legacy in immunology, expanding our portfolio to help meet the evolving needs in psoriatic disease and reinforcing our continued pursuit of innovations that improve care for ... That JAK1-selective inhibitor is intended to

  • Merck KGaA exec takes top job at UK biotech Kymab Merck KGaA exec takes top job at UK biotech Kymab

    in development across immune disease, immunology, haematology and infectious disease. ... The company’s most advanced pipeline candidate is KY1005, a potential first-in-class monoclonal antibody to treat an underlying immune system imbalance in

  • Biogen and Eisai pull plug on Alzheimer’s drug Biogen and Eisai pull plug on Alzheimer’s drug

    Alzheimer’s disease patients, their families and the investigators who participated in the trials and contributed greatly to this research,” said Michel Vounatsos, chief executive at Biogen. ... pipeline of potential therapies in Alzheimer’s

More from news
Approximately 1 fully matching, plus 52 partially matching documents found.

Latest Intelligence

  • Biotech profile: Tom Evans, CEO, Vaccitech.

    Vaccitech’s platform, which induces the cellular side of the immune system against disease targets, could be one approach in which a more powerful and durable T cell response is required.

  • Pharma deals in July 2015 Pharma deals in July 2015

    cCAM is developing an immune checkpoint protein belonging to the Human CEA (Carcino-Embryonic Antigen) protein family. ... Receptos / Celgene. Company acquisition. Ozanimod in Phase 3 for auto-immune disease.

  • Deal Watch table for May 2014 Deal Watch table for May 2014

    658. Avalanche / Regeneron. Development and commercialisation licence. Gene therapy products for ophthalmologic disease. ... MGD010, a preclinical bispecific antibody for treatment of auto-immune disease. 502.

  • Interview: AstraZeneca's Susan Galbraith Interview: AstraZeneca's Susan Galbraith

    Immuno-oncology. One area of interest for many pharma companies is the potential for immunotherapies - drugs that encourage the body's immune system to tackle a disease. ... or with other agents that might affect a different part of the immune system, or

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Body image and mental health: The psoriasis connection

    Psoriasis is an inflammatory, auto-immune skin disease, which causes the skin to grow many times faster than normal. ... 4. however the two largest contributors are the belief they are being judged on the basis of their skin disease and engaging in

  • Australian Flu and the dilemma of naming diseases

    as disease carriers, and creating negative connections between the name and the country. ... Other examples include the damaging 1980s media branding of AIDS disease as GRID (gay-related immune deficiency) and the immense impact on local tourism for

  • Random42 Proud To Be Cannes Corporate Award Winners 2016

    Silver Winner - Random 42 for Systematic Lupus Erythematosus. This animation highlights the pathogenesis of Lupus, an autoimmune disease where the body’s own immune system attacks healthy tissue. This animation was

  • Driving Earlier Diagnosis: A Case Study in Psoriatic Arthritis

    market. PsA is an auto-immune disease which causes inflammation of the joints, pain and stiffness, which is accompanied by patches of red and white, scaly skin indicative of Psoriasis.PsA ... The exact causes of the disease are not yet known, but a

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics